1: Urologe A. 2011 Jan;50(1):8-16. doi: 10.1007/s00120-010-2437-y.
Medikamentose Therapiemoglichkeiten des Oligo-Astheno-Teratozoospermie-Syndroms. Trottmann M., Kohn F.M., Dickmann M., Stief C.G., Becker A.J. Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universitat Munchen, Campus Grosshadern, Klinikum der Universitat Munchen, Marchioninistrasse 15, 81377 Munchen, Deutschland. email@example.com Medical treatment of oligoasthenoteratozoospermia (OAT) syndrome includes many different treatment concepts. The targeted causes in the treatment of OAT syndrome are either hormonal, as for example hypothalamic, pituary, or, seldom, hyperprolactinemic disturbances, or acute or chronic urogenital infections, as well as ejaculatory disorders. Often no pathogenic reason for OAT syndrome can be found and targeted. Most treatment concepts in the past tried to improve sperm quality. Administration of antiestrogens, antioxidants, hormones, and micronutrients has been tried and used to improve sperm quality. The present article provides an overview of current medical treatment options for OAT syndrome, including former unsuccessful treatment concepts. The article furthermore sketches out potential treatment options, which might be available in the future.